Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Nashville, Tennessee 37232


Purpose:

Asthma is a common respiratory disease of unknown etiology which currently affects approximately 7.5 % of the adult population ( ). Asthma is an inflammatory disorder of the airways. Airway inflammation is evident not only in patients with fatal asthma but also in mild asthmatics ( ). Oxidant stress, defined as inadequately controlled generation of toxic reactive oxygen species (ROS) in the cells or tissues is a common feature of inflammation, and has also been documented in asthma ( , ). However, the current understanding of the relationship between the inflammation and the oxidant stress in asthmatic airways is poor. Does oxidant stress contribute to the expression of asthmatic phenotypes independently of inflammation? If so, could asthmatics benefit from supplementation of antioxidants? These questions have been nagging us since our laboratory provided credible evidence of oxidant injury in the airways of allergic asthmatics ( ). The purpose of our study is to more precisely determine 1/ the pathophysiologic role of oxidative stress, and 2/ usefulness of antioxidant therapy using vitamin E in allergic asthma.


Criteria:

Inclusion Criteria: - Normal health status except for allergic asthma - Physician diagnosis of mild allergic asthma - Positive allergen skin tests to common aeroallergens Exclusion Criteria: - Use of systemic or high doses of inhaled corticosteroids, >840 mcg of inhaled beclomethasone of its equivalent (as defined in the consensus report (6)) - Past history of severe asthma (as defined in the consensus report (6)) - History of asthma exacerbation within the past month - History of recent upper respiratory infection within the past month - Active immunotherapy for allergic diseases - Significant disease other than allergic asthma and allergic rhinitis, such as coronary disease, hypertension, renal failure, anemia, immunodeficiency, cancer, diabetes - Present or remote tobacco smoking - Use of Over The Counter drugs including acetaminophen and pseudoephedrine, herbs, or vitamins - Psychiatric illness that would make adherence to protocol difficult - Inability to give informed consent - Nursing or pregnant women - Woman planning to become pregnant during the study or not using adequate birth control methods (barrier or hormonal methods) - H/o sensitivity to tocopherol-derivatives or medications used during bronchoscopy - Inability to comply with the research protocol


NCT ID:

NCT00581048


Primary Contact:

Principal Investigator
Ryszard Dworski, MD
Vanderbilt University


Backup Contact:

N/A


Location Contact:

Nashville, Tennessee 37232
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.